ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00674297
Recruitment Status : Unknown
Verified February 2013 by Doruk Erkan, Hospital for Special Surgery, New York.
Recruitment status was:  Active, not recruiting
First Posted : May 7, 2008
Last Update Posted : February 5, 2013
Sponsor:
Collaborator:
University of Texas
Information provided by (Responsible Party):
Doruk Erkan, Hospital for Special Surgery, New York

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Actual Primary Completion Date : July 2011
  Study Completion Date : No date given

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 April 21, 2017 May 31, 2017
2 August 1, 2017 August 30, 2017
3 September 14, 2017  
4 October 2, 2017 October 31, 2017
5 March 29, 2018